Emerging drugs for managing kidney disease in patients with diabetes

Author： Thomas Merlin C  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.18, Iss.1, 2013-03, pp. : 55-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for chronic kidney disease

By Stefoni Sergio   Cianciolo Giuseppe   Baraldi Olga   Iorio Mario   Angelini Maria Laura  

Expert Opinion on Emerging Drugs, Vol. 19, Iss. 2, 2014-06 ,pp. : 183-199

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for treatment of anemia of chronic kidney disease

By Magwood Jametta S   Lebby Akida   Chen Brian   Kessler Sam   Norris LeAnn   Bennett Charles L  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 4, 2013-12 ,pp. : 421-429

Informa Healthcare

Access to resources Recommend Favorite

Emerging Immunosuppressive Drugs in Kidney Transplantation

By  

Current Clinical Pharmacology, Vol. 6, Iss. 2, 2011-05 ,pp. : 130-136

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease

By Scheen André J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 5, 2013-05 ,pp. : 529-550

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs to treat Crohn's disease

By Strauch Ulrike   Schölmerich Jürgen  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 309-322

Informa Healthcare

Access to resources Recommend Favorite